Prevalence of Non-alcoholic Fatty Liver Disease in Patients With Chronic Kidney Disease in Assiut
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- CKD
- Sponsor
- Muhammad Ameen Abdelrady Abdelaziz
- Enrollment
- 200
- Primary Endpoint
- abdominal ultrasound
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The goal of this observational study is to detect the prevalence of NAFLD in CKD patients
The main question[s] it aims to answer are:
- [question 1] prevalence of NAFLD in CKD patients.
- [question 2] the relationship between NAFLD and CKD.
Detailed Description
The goal of this observational study is to detect the prevalence of NAFLD in CKD patients The main question\[s\] it aims to answer are: * \[question 1\] prevalence of NAFLD in CKD patients. * \[question 2\] the relationship between NAFLD and CKD.
Investigators
Muhammad Ameen Abdelrady Abdelaziz
Internal Medicine Resident
Assiut University
Eligibility Criteria
Inclusion Criteria
- •CKD patients
Exclusion Criteria
- •HCV and HBV Positive patients
- •Alcoholics
- •patient on Hemodialysis
- •patients with wilson disease
- •patients with alpha one antitrypsin deficiency
Outcomes
Primary Outcomes
abdominal ultrasound
Time Frame: 1 year
assessment of Liver regarding fatty liver disease by Ultrasound.
Complete Blood Picture (WBCs, HB, Patelets
Time Frame: 1 year
total leucocytic count Hemoglobin level and platelet count will be assessed in our patients and will be reported in a table
Fibroscan
Time Frame: 1 year
participants will undergo fibroscanning of the liver to assess NAFLD and results will be reported in a table.
Lipid Profile
Time Frame: 1 year
participants will be assessed regarding Cholesterol level, Triglycerides, HDL and LDL. results will be reported in a table
liver enzymes
Time Frame: 1 year
participants will undergo assessment of liver enzymes (AST and ALT) and results will be reporeted in a table.
BUN, Cr level and estimated GFR
Time Frame: 1 year
participants will be assessed regarding BUN, CR and estimated GFR to confirm and follow up CKD patients involved in the study.
serum Uric Acid
Time Frame: 1 year
serum uric acid will be assessed and reported in our patients
Secondary Outcomes
- Body Mass Index(1 year)
- Waist Circumference(1 year)